The Alfred Research Alliance today welcomed Victoria’s Lead Scientist, Dr Amanda Caples, for a tour of the Alfred precinct and a round-table with senior personnel from Alliance member organisations.
A delegation including Prof Andrew Way, Chief Executive of Alfred Health and Chair of the Alliance Council and Dr Renée Dutton, Executive Officer of the Alfred Research Alliance, welcomed Dr Caples and provided an overview of the precinct’s capacity, capabilities and achievements, and its plans for the future.
Dr Caples then toured Nucleus Network, Australia’s largest Phase 1 clinical research organisation, where multiple clinical trials, including some into COVID vaccines, are underway. The facility is just one example of the extensive infrastructure and resources at the Alfred precinct which have been made possible in part by significant past investment by the Victorian Government.
The tour was followed by a round-table discussion with the leadership of the Alfred Research Alliance, giving Dr Caples the opportunity to review the impact of previous government investment, and how the future health needs of Victorians will be best supported through translational research and medicine.
The Alfred Research Alliance translational research and medical precinct is a collaborative community of more than 8000 people across eight member organisations: Alfred Health, Monash University, Baker Heart & Diabetes Institute, Burnet Institute, La Trobe University, Deakin University, Nucleus Network and 360biolabs.
Photos: Dr Renée Dutton, Executive Officer, Alfred Research Alliance